Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-26-039816

EXEC. CHAIR & PRINCIPAL OFF bought 20,000 shares at $0.65 ($13,000)

From the SEC's structured data for this filing

Trades in this filing

ARMEN GARO H · EXEC. CHAIR & PRINCIPAL OFF

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-21 Purchase : show line 1 in the form +20,000 $0.65 $13,000 73,533 D
Open-market purchases · 20,000 sh · avg $0.65 · $13,000
Loading xslF345X06/ownership.xml…